Elevated TJP2 protein combines with extracellular signal-regulated kinase 2 (ERK2) to promote ERK2 protein expression which suppresses the phosphorylation of ERK2, thereby inhibiting the growth and metastasis of ccRCC [34]. This evidence concerns the gene MAPK1 and nonpapillary renal cell carcinoma.